JP2011525106A5 - - Google Patents

Download PDF

Info

Publication number
JP2011525106A5
JP2011525106A5 JP2011512668A JP2011512668A JP2011525106A5 JP 2011525106 A5 JP2011525106 A5 JP 2011525106A5 JP 2011512668 A JP2011512668 A JP 2011512668A JP 2011512668 A JP2011512668 A JP 2011512668A JP 2011525106 A5 JP2011525106 A5 JP 2011525106A5
Authority
JP
Japan
Prior art keywords
hla
expression product
patient
level
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011512668A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011525106A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/046314 external-priority patent/WO2009149297A1/en
Publication of JP2011525106A publication Critical patent/JP2011525106A/ja
Publication of JP2011525106A5 publication Critical patent/JP2011525106A5/ja
Pending legal-status Critical Current

Links

JP2011512668A 2008-06-04 2009-06-04 瀰漫性ｂ大細胞型リンパ腫のマーカーおよびその使用方法 Pending JP2011525106A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13102708P 2008-06-04 2008-06-04
US61/131,027 2008-06-04
PCT/US2009/046314 WO2009149297A1 (en) 2008-06-04 2009-06-04 Diffuse large b-cell lymphoma markers and uses therefor

Publications (2)

Publication Number Publication Date
JP2011525106A JP2011525106A (ja) 2011-09-15
JP2011525106A5 true JP2011525106A5 (enExample) 2012-05-31

Family

ID=41055125

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011512668A Pending JP2011525106A (ja) 2008-06-04 2009-06-04 瀰漫性ｂ大細胞型リンパ腫のマーカーおよびその使用方法

Country Status (5)

Country Link
US (2) US20110159492A1 (enExample)
EP (1) EP2297349A1 (enExample)
JP (1) JP2011525106A (enExample)
CA (1) CA2726426A1 (enExample)
WO (1) WO2009149297A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101968491A (zh) * 2010-09-29 2011-02-09 上海生物芯片有限公司 弥漫性大b细胞淋巴瘤分子病理分型方法及试剂盒和应用
KR101320633B1 (ko) * 2011-05-25 2013-10-30 엠앤디 (주) 실시간 중합반응을 이용한 암의 진단을 위한 정보제공방법 및 이를 위한 암 진단용 키트
US10260097B2 (en) 2011-06-02 2019-04-16 Almac Diagnostics Limited Method of using a gene expression profile to determine cancer responsiveness to an anti-angiogenic agent
US8592156B2 (en) * 2011-08-08 2013-11-26 Roche Molecular Systems, Inc. Predicting response to anti-CD20 therapy in DLBCL patients
ES2634254T3 (es) 2011-09-12 2017-09-27 Atrys Health, SA Métodos para el pronóstico del linfoma difuso de linfocitos B grandes
CN107884560A (zh) * 2012-04-04 2018-04-06 辛辛那提大学 汗液模拟、收集和感测系统
HK1214633A1 (zh) 2012-12-03 2016-07-29 Almac Diagnostics Limited 癌症的分子诊断测试
GB201409479D0 (en) 2014-05-28 2014-07-09 Almac Diagnostics Ltd Molecular diagnostic test for cancer
WO2019065901A1 (ja) * 2017-09-29 2019-04-04 国立大学法人九州大学 びまん性大細胞型ｂ細胞リンパ腫患者における化学療法に対する治療効果を予測するための方法及びキット
WO2019173991A1 (zh) * 2018-03-14 2019-09-19 深圳华大生命科学研究院 恶性淋巴瘤标志物及其应用
WO2020041691A1 (en) * 2018-08-24 2020-02-27 City Of Hope Oligonucleotide inhibitors of nuclear factor kappa-light-chain-enhancer
WO2021026335A1 (en) * 2019-08-08 2021-02-11 The Trustees Of Indiana University Methods for identifying and treating urinary tract infections
WO2022093910A1 (en) * 2020-10-27 2022-05-05 The Children’S Mercy Hospital Prognostic gene signature and method for diffuse large b-cell lymphoma prognosis and treatment
WO2025151077A1 (en) * 2024-01-08 2025-07-17 National University Of Singapore A method to predict and target resistance to chemotherapy in a cancer

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5800992A (en) * 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US5143854A (en) * 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5837832A (en) * 1993-06-25 1998-11-17 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
US5795716A (en) * 1994-10-21 1998-08-18 Chee; Mark S. Computer-aided visualization and analysis system for sequence evaluation
US5953727A (en) * 1996-10-10 1999-09-14 Incyte Pharmaceuticals, Inc. Project-based full-length biomolecular sequence database
US6484183B1 (en) * 1997-07-25 2002-11-19 Affymetrix, Inc. Method and system for providing a polymorphism database
US6232066B1 (en) * 1997-12-19 2001-05-15 Neogen, Inc. High throughput assay system
US6238869B1 (en) * 1997-12-19 2001-05-29 High Throughput Genomics, Inc. High throughput assay system
US6185561B1 (en) * 1998-09-17 2001-02-06 Affymetrix, Inc. Method and apparatus for providing and expression data mining database
EP1561814B1 (en) * 2002-10-22 2010-12-22 Eisai R&D Management Co., Ltd. Gene specifically expressed in postmitotic dopaminergic neuron precursor cells
US7332280B2 (en) * 2003-10-14 2008-02-19 Ronald Levy Classification of patients having diffuse large B-cell lymphoma based upon gene expression
US7939251B2 (en) * 2004-05-06 2011-05-10 Roche Molecular Systems, Inc. SENP1 as a marker for cancer

Similar Documents

Publication Publication Date Title
US12077803B2 (en) MicroRNAs as biomarkers for endometriosis
Matsuura et al. Circulating let‐7 levels in plasma and extracellular vesicles correlate with hepatic fibrosis progression in chronic hepatitis C
Tang et al. Selection of aptamers for molecular recognition and characterization of cancer cells
Goren et al. Serum levels of microRNAs in patients with heart failure
CN101809169B (zh) 通过靶向dnmt3a和dnmt3b恢复甲基化的方法
Stahlhut et al. MicroRNAs and the cancer phenotype: profiling, signatures and clinical implications
Santos et al. Helicobacter pylori infection modulates the expression of miRNAs associated with DNA mismatch repair pathway
Decmann et al. Circulating miRNA expression profiling in primary aldosteronism
El‐Mayta et al. A nanoparticle platform for accelerated in vivo oral delivery screening of nucleic acids
EP3036326B1 (en) Inhibition of a lncrna for treatment of melanoma
Andia et al. DNA methylation status of the IL8 gene promoter in aggressive periodontitis
JP2012500389A5 (enExample)
EP2734636B1 (en) Micro-rna biomarkers for identifying risk of and/or for diagnosing lung tumour
CN111356774A (zh) 用于检测衰老细胞的新型生物标记物
JP2009536828A5 (enExample)
WO2007135568A3 (en) A METHOD FOR PREDICTING RESPONSIVENESS TO TNFα BLOCKING AGENTS
JP2014527807A5 (enExample)
JP2014533114A5 (enExample)
JP2018504909A5 (enExample)
Rawat et al. MicroRNA in intestinal tight junction regulation
JP6800470B2 (ja) ｍｉＲＮＡをマーカーとする歯周炎検査キット、及び検査方法
JP2023113680A (ja) 疾患・体質の分析方法、疾患・体質の分析システム、プログラムおよびコンピュータ読み取り可能な記録媒体
CN106103714B (zh) 体内感染微生物、寄生微生物、共生微生物的非编码性rna及其鉴定和应用
CN102732616A (zh) 检测CDH23基因c.403C>T突变的试剂盒
CN110129444A (zh) 一种检测放射性损伤的试剂及其应用